Quadrant Capital Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Sell |
7,622
-359
| -4% | -$45.1K | 0.03% | 502 |
|
|
2025
Q1 | $883K | Buy |
7,981
+5,692
| +249% | +$630K | 0.03% | 428 |
|
|
2024
Q4 | $312K | Sell |
2,289
-23
| -1% | -$3.14K | 0.02% | 474 |
|
|
2024
Q3 | $266K | Sell |
2,312
-46
| -2% | -$5.3K | 0.02% | 556 |
|
|
2024
Q2 | $325K | Buy |
2,358
+252
| +12% | +$34.7K | 0.02% | 461 |
|
|
2024
Q1 | $290K | Buy |
2,106
+31
| +1% | +$4.28K | 0.02% | 485 |
|
|
2023
Q4 | $273K | Buy |
2,075
+78
| +4% | +$10.3K | 0.02% | 477 |
|
|
2023
Q3 | $225K | Buy |
1,997
+765
| +62% | +$86.1K | 0.02% | 483 |
|
|
2023
Q2 | $116K | Buy |
1,232
+405
| +49% | +$38.2K | 0.01% | 779 |
|
|
2023
Q1 | $83.7K | Sell |
827
-478
| -37% | -$48.4K | 0.01% | 942 |
|
|
2022
Q4 | $156K | Buy |
1,305
+367
| +39% | +$43.8K | 0.02% | 566 |
|
|
2022
Q3 | $100K | Buy |
938
+601
| +178% | +$64.1K | 0.01% | 696 |
|
|
2022
Q2 | $33K | Sell |
337
-58
| -15% | -$5.68K | ﹤0.01% | 1056 |
|
|
2022
Q1 | $37K | Buy |
395
+389
| +6,483% | +$36.4K | ﹤0.01% | 1050 |
|
|
2021
Q4 | $1K | Sell |
6
-184
| -97% | -$30.7K | ﹤0.01% | 2347 |
|
|
2021
Q3 | $18K | Buy |
190
+131
| +222% | +$12.4K | ﹤0.01% | 1298 |
|
|
2021
Q2 | $6K | Sell |
59
-47
| -44% | -$4.78K | ﹤0.01% | 1782 |
|
|
2021
Q1 | $10K | Buy |
106
+23
| +28% | +$2.17K | ﹤0.01% | 1501 |
|
|
2020
Q4 | $8K | Sell |
83
-215
| -72% | -$20.7K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $29K | Sell |
298
-439
| -60% | -$42.7K | 0.01% | 826 |
|
|
2020
Q2 | $90K | Buy |
737
+32
| +5% | +$3.91K | 0.02% | 487 |
|
|
2020
Q1 | $61K | Buy |
705
+21
| +3% | +$1.82K | 0.01% | 789 |
|
|
2019
Q4 | $72K | Hold |
684
| – | – | 0.01% | 1147 |
|
|
2019
Q3 | $60K | Hold |
684
| – | – | 0.01% | 1146 |
|
|
2019
Q2 | $56K | Buy |
684
+30
| +5% | +$2.46K | 0.01% | 1167 |
|
|
2019
Q1 | $56K | Buy |
654
+647
| +9,243% | +$55.4K | 0.01% | 1147 |
|
|
2018
Q4 | $0 | Sell |
7
-69
| -91% | – | ﹤0.01% | 2262 |
|
|
2018
Q3 | $9K | Hold |
76
| – | – | ﹤0.01% | 1339 |
|
|
2018
Q2 | $7K | Hold |
76
| – | – | ﹤0.01% | 1437 |
|
|
2018
Q1 | $6K | Hold |
76
| – | – | ﹤0.01% | 1478 |
|
|
2017
Q4 | $5K | Buy |
+76
| New | +$5K | ﹤0.01% | 1475 |
|
|
2017
Q1 | – | Sell |
-114
| Closed | -$4K | – | 2109 |
|
|
2016
Q4 | $4K | Sell |
114
-172
| -60% | -$6.04K | ﹤0.01% | 1307 |
|
|
2016
Q3 | $14K | Hold |
286
| – | – | 0.01% | 911 |
|
|
2016
Q2 | $13K | Buy |
+286
| New | +$13K | 0.01% | 899 |
|
|
2016
Q1 | – | Sell |
-121
| Closed | -$6K | – | 1911 |
|
|
2015
Q4 | $6K | Buy |
+121
| New | +$6K | ﹤0.01% | 994 |
|